Skip to main content
. 2022 Apr 21;23(9):4610. doi: 10.3390/ijms23094610
AD Alzheimer’s disease
ALS Amyotrophic lateral sclerosis
Amyloid β
BACE1 Beta-site APP-cleaving enzyme 1
BBB Blood–brain barrier
CCH Chronic cerebral hypofusion
CIS Clinically isolated syndrome
CNS Central nervous system
CSF Cerebrospinal fluid
DS Down syndrome
EBV Epstein–Barr virus
EOAD Early-onset Alzheimer’s disease
FLC Immunoglobulin-free light chains
HLA Human leukocyte antigen
KFLC Kappa-free light chains
LFLC Lambda-free light chains
LOAD Late-onset Alzheimer’s disease
MCI Mild cognitive impairment
miRNAs microRNAs
MMPs Matrix metalloproteinases
MS Multiple sclerosis
NDs Neurodegenerative diseases
Nf-L Neurofilament light chains
NFTs Neurofibrillary tangles
NF-κB Nuclear factor κB
NGS Next-generation deep sequencing
PD Parkinson’s disease,
pNfH Phosphorylated neurofilament heavy chains
PPMS Primary progressive MS
pTau Phosphorylated tau
pTau181 Tau phosphorylated at threonine 181
ROS Reactive oxygen species
RRMS Relapsing–remitting MS
SOD1 Superoxide dismutase 1
SPMS Secondary progressive MS
TDP-43 Transactive response DNA-binding protein 43 kDa
tTau Total tau protein